pros and cons of glp-1 Is a right for you? Since the widespread adoption GLP-1 receptor agonists like Ozempic, Wegovy Munjaro for the management of metabolic disease and weight loss, there's been a growing GLP-1 Medications for Weight Loss:

Vanhaverbeke M, Veltman D, Janssens S, Sinnaeve PR (2021) Peripheral blood RNAs and left ventricular dysfunction after myocardial infarction: towards translation into clinical practice

2015;10: e0120440

8 ways you may be sabotaging your sleep The Fortune 500 Innovation Forum will convene Fortune 500 executives, U.S

Drug Name: Semaglutide Manufacturer: Novo Nordisk Type: GLP-1 agonist Brand Names: Ozempic = Type 2 Diabetes, weekly injection (approved December, 2017) Rebylsus = Type 2 Diabetes, daily pill (approved September, 2019) Wegovy = Weight Loss, weekly injection (approved June, 2021) Drug Name: Tirzepatide Manufacturer: Eli Lilly Type: GLP-1/GIP co-agonist Brand Names: Mounjaro = Type 2 Diabetes, weekly injection (approved May, 2022) Zepbound = Weight Loss Application, weekly injection (approved November, 2023) (No pill form exists as of this writing) The short story is that both drugs were originally introduced as effective Type 2 Diabetes medications